Tech Company Financing Transactions

Dimension Therapeutics Funding Round

Dimension Therapeutics, operating out of Cambridge, secured $65 million from New Leaf Venture Partners, F-Prime Capital and Jennison Associates.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

840 Memorial Drive
Cambridge, MA 02139
USA

Phone

617-401-0011

Website

www.dimensiontx.com

Email Address

[email protected]

Overview

Dimension Therapeutics, Inc., is a leading rare disease company focused on developing novel treatments for devastating disorders associated with the liver and based on an industry-leading, extensively validated adeno-associated virus (AAV) platform.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Annalisa Jenkins

        

Chief Financial Officer

Jean Franchi

        

Chief Medical Officer

Eric Crombez

        

Chief Scientific Officer

Sam Wadsworth

        

VP - Bus. Development

Andy Hu

        

VP - Human Resources

Rachel Strauss

        

VP - Manufacturing

Reed Clark

        

VP - Operations

Stephanie Haller

        

VP - Regulatory Affairs

Khandan Baradaran

        

Browse more venture capital transactions:

Prev: 4/21/2015: Pathar venture capital transaction
Next: 4/21/2015: Contego Medical venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary